President Trump announced fresh sanctions on the Islamic Republic on Monday, following the downing of an unmanned American drone last week.Politicsread more
President Donald Trump's son-in-law Jared Kushner has presented a $50 billion investment plan for economic growth and peace in the Middle East that has been greeted with...World Politicsread more
Stocks should rally if the U.S. and China agree to new negotiations and a ceasefire in the trade war, but the economic impact of tariffs will continue.Market Insiderread more
The trade war between Beijing and Washington appears to have depressed Chinese property purchases in the United States. China's own actions may also be playing a role.Real Estateread more
Tesla CEO Elon Musk sent out another email to his employees, pushing them to aim for a record number of vehicle deliveries to end the second quarter of 2019.Technologyread more
More than 300 companies are talking to government officials in Washington about how detrimental the trade war is.Marketsread more
Democrats want Mueller's testimony on his probe into Russian interference in the 2016 election and Trump's efforts to influence it.Politicsread more
The Senate is expected to pass its own version of the border aid legislation, while the Trump administration has threatened to veto both bills.Politicsread more
Some 4 million people have fled the South American country since 2015 amid an economic meltdown.World Politicsread more
Japanese designer Undercover posted on its Instagram account a photo of protesters with the slogan "no extradition to China," the Financial Times reported.China Politicsread more
Powell stresses the central bank's independence in a speech that comes amid continuous pressure from the White House to cut interest rates.The Fedread more
Baxter International shares fell Monday, the first trading day after the medical supplies company said one of its employees received a grand jury subpoena in a case about intravenous saline pricing and sales.
The stock dropped about 1.4 percent shortly after the open Monday but recovered about half its losses within the first hour. Shares of Baxter closed down almost 1 percent at $52.82 per share.
Baxter said Friday the subpoena, obtained by federal investigators, is "pursuant to a criminal investigation." It calls for the employee to produce documents and testimony related to pricing, shortages of Baxter's intravenous solutions "and communications with competitors regarding the same," the company said.
Baxter disclosed in February that the New York attorney general had asked for information about its business practices in the IV saline industry, and a class action lawsuit filed last year accused the pharmaceutical company of participating in a conspiracy of sorts to "fix" saline solution prices.
Revenues in the company's so-called fluid systems segment, which includes the intravenous saline sales being called into question, was $2.3 billion last year, representing slightly more than 25 percent of total sales.
The health-care company said in Friday's SEC filing that it is cooperating with this latest criminal investigation.